Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hmmm Shell being sold what or bought could explain increases but who.
The company was closed 2 years ago and didn't exist anymore. The people are buying Air paper for Nothing!
You been getting that good shit?
It's the real news (TRUTH);
like LootForMe2 and others need to know about this shell. This ticker is for pumpers only. No one should waste their time and money here. As soon as I posted the TRUTH yesterday this ticker sank like a rock. Only pumpers will keep it on life support. And I am sure I was not the first to point out the TRUTH!
"Nothing here", Not old news Only News NoBody's Home,Most current Pump & Dump is over here BEWARE
Show us some new news?????? 14 posts Bullshit
New Buyers Buy at your own Risk I'm Done here
QUIT...POSTING...OLD...NEWS!!!!
I am considering buying some shares of ULGX. However, am unable to find anything current about this. Is it a shell? Is there even a company behind this ticker? Why all the volume on a ticker that is faceless?
Urologix Inc. (OCT:ULGX) yesterday(2/3/2016) said it sold almost all of its assets to a secured creditor, which then sold them to a private company that will operate the business as Urologix LLC. The remnants of Urologix Inc. were renamed 21st North Inc.
The Minneapolis-based company, which makes the Cooled ThermoTherapy and Prostiva RF devices to treat benign prostatic hyperplasia, licensed Prostiva from Medtronic (NYSE:MDT).
As of March 31, 2015, Urologix owed its Twin Cities neighbor some $2.8 million, according to a regulatory filing, and lacked the scratch to pay up. All of its assets, including intellectual property, were put up as collateral to Medtronic, according to the filing. The nut consisted of a $1.3 million payment due on a $5.3 million promissory note and $1.5 million in royalties and other fees.
Last May, Urologix said it defaulted on the debt April 14, 2015, and was pursuing “strategic alternatives” to raise enough cash to pay the debt.
“The company’s ability to continue as a going concern is dependent upon its ability to address the outstanding indebtedness to Medtronic,” Urologix said at the time.
The asset sale “will enable Urologix LLC to provide urology customers and their patients with both Cooled ThermoTherapy and Prostiva RF Therapy products and services to treat BPH in the comfortable setting of a urologist’s office,” the company said.
“Immediately following the transaction, 21st North Inc. has no operations and has commenced an orderly wind down. Accordingly, 21st North intends to submit a proposal to its shareholders in the ensuing weeks to approve a plan of dissolution. The company will not be making liquidating distributions to shareholders at any time,” according to a press release.
21st North Inc bought Urologix
14405 21st Ave N
MINNEAPOLIS MN 55447-4685
P: +1612.4751400
F: +1763.4048118
That's what some do. Look at their posts.
Out of curiosity, why are such a Good Samaritan and warning everyone about this stock? Asking for a friend.
Normally, when OTC gives a Warning like this, it'll suspend and cancel the Scam stock shortly! You'll lose all your money!
This company was shut down 3 years ago and doesn't Exist! You're buying a Air paper!
Where are those Pumpers who bought at $0.005?
The company doesn't Exist anymore!
Warning: ULGX: The site you were looking for is no longer available at this IP address.
Look at this: Those who bought at $0.005 are pumping hard:
2018-05-18 Q ULGX 0.012 0.017 0.01 0.0165 0.001 1,740,803 71 0.0095 0.03
2018-05-17 Q ULGX 0.0107 0.0185 0.0074 0.0155 0.0038 1,191,086 48 0.012 0.0155
2018-05-16 Q ULGX 0.0099 0.012 0.0095 0.0117 0.0017 161,000 11 0.0001 0.012
2018-05-15 Q ULGX 0.014 0.014 0.0085 0.01 -0.004 3,100,756 64 0.0001 0.012
2018-05-14 Q ULGX 0.012 0.015 0.0105 0.014 0.00362 1,953,812 110 0.0106 0.0169
2018-05-11 Q ULGX 0.00831 0.011 0.0078 0.01038 0.00258 2,107,645 57 0.0001 0.4672
2018-05-10 Q ULGX 0.0078 0.0078 0.0078 0.0078 0.0002 1,700 2 0.0001 0.2579
2018-05-09 Q ULGX 0.00785 0.00785 0.0065 0.0076 0.0011 158,300 5 0.006 0.2579
2018-05-08 Q ULGX 0.0064 0.0079 0.006 0.0065 0.0005 1,006,841 27 0.006 0.2579
2018-05-07 Q ULGX 0.0041 0.006 0.0041 0.006 0.0008 736,218 30 0.0041 0.2579
2018-05-04 Q ULGX 0.004 0.0052 0.0038 0.0052 0.00021 665,388 13 0.004 0.1047
2018-05-03 Q ULGX 0.0057 0.0057 0.00485 0.00499 0.00024 185,100 7 0.0001 0.006
2018-05-02 Q ULGX 0.0055 0.0057 0.004 0.00475 -0.00075 356,300 12 0.0033 0.006
2018-05-01 Q ULGX 0.003 0.006 0.0027 0.0055 1,534,043 33 0.0033 0.006
OTC Warning! This company (Urologix Inc.) may not be making material information publicly available
Buying or selling this security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.
Strong close today = continue bounce tomorrow
Ulgx looking great beast is about to wake again definitely going over. 08, been buying today bought a nice position. Short volume is hugeeeee
just checked the shorts vol, its 1.7 million, definitely moving up
Teddy, you are a hundred percent correct.
Nice Day on this low Floater. .10 is what the chart says it will hit first
Chap, these are low float, low o/s, with low A/s, no convertible debt stocks that easily move. Unfortunately, the MM,s caused a panic with a sell off so they could cover their shorts lower. This will rebound back to .16-.25 levels
What a day....some individuals sabotage this ticker. But it is rebounding very well.....15 here we come
When I make over $10k in a year in OTC, I call that a risky investment that paid off. I certainly did not donate to a stock. It's all pocket change to me anyway. I pay my financial planners for the NASDAQ and Dow Jones portfolio investments.
And who "invests" in OTC and pinks?
Bye, Felicia!
So, 5 minutes of DD tells me to move on. Nothing to see. I can afford 5 minutes to research and decide to NOT invest here.
So, with the evidence I found, earlier posts today, nothing is evident in which to make a investment decision - for me. I only heard about this stock Friday.
What evidence exists that drives this stock up to .15 and then back down to .018 and now .033? No 2017/18 SEC filings, No PRs, no kind of news.
lmao You have anything more recent??? Show us your Stuff mr 40 post man joined a month ago & knows everything! Have another user id???
You can swing trade this all the way up to .14 at least.
Catching up with the facts leading today, history (I've not seen any filings or news from this company);
Urologix Announces SEC DeregistrationPress Release | 07/09/2015
MINNEAPOLIS, July 09, 2015 (GLOBE NEWSWIRE) -- Urologix, Inc. (OTCQB:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced its decision to terminate and suspend the registration of its stock with the Securities and Exchange Commission (the “SEC”). The Company also intends to cause its common stock to cease trading on the OTCQB and commence trading on the OTC Pink marketplace. For more information about the OTC Pink marketplace, please see www.otcmarkets.com.
The Company intends to file a Form 15 with the SEC to voluntarily deregister its common stock and suspend its reporting obligations under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on or about July 10, 2015. As a result of the filing of the Form 15, the Company’s obligation to file certain Exchange Act reports and forms with the SEC, including Forms 10-K, 10-Q, and 8-K, will cease. Other filing requirements will terminate upon the effectiveness of the deregistration, which is expected to occur 90 days after the filing of the Form 15.
The Company’s board of directors decided to deregister and terminate Exchange Act reporting after careful consideration of the advantages and disadvantages of being an SEC reporting company. The Company’s board of directors considered many factors in making this decision, including the following:
* the costs, both direct and indirect, associated with the preparation and filing periodic reports with the SEC, including the continually escalating costs and burdens associated with complying with recent legislation applicable to reporting companies such as the Sarbanes-Oxley Act of 2002 and the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010;
* the additional demands placed on management and Company personnel to comply with requirements required of registrants;
* the historically low stock price of the Company’s common stock;
* the nature and extent of the trading in the Company’s common stock;
* the current level of analyst coverage and minimal liquidity for the Company’s common stock;
* and the value of an SEC-registered entity to potential strategic partners.
The board’s decision to deregister was made in conjunction with the board’s continuing review of various strategic alternatives available to the Company, including the sale of the Company or its assets, partnering or other collaboration agreements, or a merger, reverse merger or other strategic transaction. The board of directors decided that the Company should deregister with the SEC as it believes that the cost savings outweigh the potential benefits of continuing as an SEC registered company. Without the annual accounting expenses, legal costs, and administrative burden relating to SEC reporting obligations and compliance, the Company will be able to significantly reduce its costs and focus on the pursuit of alternatives to address the Company’s obligations to its creditors, primarily Medtronic, Inc. As of June 30, 2015, the Company’s cash balance was approximately $430,000 and there was a total of $7.4 million due to Medtronic.
I owe you an apology. Both the UROLOGIX Inc. (OTC) and UROLOGIX LLC (company web site) describe the same Company Profile, yet...
my msg to them this morning;
Thank you for your inquiry.
UROLOGIX, LLC is a standalone, privately-held entity with no relation to the former Urologix, Inc. public company. Our company has nothing to do with the remaining Urologix, Inc. shell, and the shell has no assets or operations today.
All the best,
Juana M. Sigala
Customer Service Lead
Urologix, LLC
888-229-0772 (P) / 763-404-8118 (F)
www.urologix.com
Yeah, acting like 2yr old news is new, is definitely #fakenews
I think can bounce to the .04-.05 range
"SirBika Monday, 02/12/18 11:39:31 AM
Re: l2 hunter post# 279 0
Post #
280
of 724
ULGX - "As previously reported, the publicly-traded entity, Urologix Inc., was renamed 21st North Inc., which has no operations and plans to dissolve. All Urologix Inc. assets have been acquired by Urologix LLC."
http://www.urologix.com/wp-content/uploads/2016/02/Urologix-PressRelease-021016.pdf "
Right you were Was taken private long time ago, nothing here
Followers
|
22
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
826
|
Created
|
05/03/06
|
Type
|
Free
|
Moderators |
Headquarters: 14405 21ST AVE N MINNEAPOLIS, MN 55447 | |
Web Address: http://www.urologix.com/ |
Filing Date | Trade Date | Insider Name | Event Code | Ownership | Trade Information | Holding % Change | |
Jan 22/14 | Nov 07/13 | DANN MITCHELL Director | A | Direct ownership | Acquired 50,000 Common Stock | 11.50% | |
Jan 22/14 | Nov 07/13 | EMERY SIDNEY W JR Director | A | Direct ownership | Acquired 50,000 Common Stock | 56.45% | |
Jan 22/14 | Nov 07/13 | Barys Christopher R Director | A | Direct ownership | Acquired 50,000 Common Stock | 83.61% | |
Jan 22/14 | Nov 07/13 | Spangler Patrick D Director | A | Direct ownership | Acquired 50,000 Common Stock | 83.61% | |
Aug 28/13 | Aug 26/13 | Fluet Gregory CEO | P | Direct ownership | Acquired 17,500 Common Stock at $0.31 | 0.00% | |
Aug 16/13 | Aug 14/13 | Ackermann Lisa A EVP, Sales & Marketing | A | Direct ownership | Acquired 35,000 Stock Option (Right-to-Buy) | 0.00% | |
Aug 16/13 | Aug 14/13 | Ackermann Lisa A EVP, Sales & Marketing | A | Direct ownership | Acquired 35,000 Restricted Stock | 76.70% | |
Aug 16/13 | Aug 14/13 | Smrdel Brian J Chief Financial Officer | A | Direct ownership | Acquired 17,500 Stock Option (Right-to-Buy) | 0.00% | |
Aug 16/13 | Aug 14/13 | Smrdel Brian J Chief Financial Officer | A | Direct ownership | Acquired 15,000 Restricted Stock | 0.00% | |
Jul 15/13 | Jul 12/13 | DANN MITCHELL Director | P | Direct ownership | Acquired 20,000 Common Stock at $0.30 | 4.82% |
Date | Name-Position | Transaction | Shares | Price Range ($) | Shares Held | Mkt Value |
---|---|---|---|---|---|---|
11/7/13 | Spangler Patrick D Director | Award of Options | 50,000 | 0.000 – 0.000 | 109,802 | $0.0 |
Dann Mitchell Director | Award of Options | 50,000 | 0.000 – 0.000 | 556,933 | $0.0 | |
Emery Sidney W Jr Director | Award of Options | 50,000 | 0.000 – 0.000 | 209,823 | $0.0 | |
Barys Christopher R Director | Award of Options | 50,000 | 0.000 – 0.000 | 109,802 | $0.0 | |
8/26/13 | Fluet Gregory J Chief Executive Officer | Purchase | 17,500 | 0.310 – 0.310 | 229,374 | $5.4 K |
8/14/13 | Fluet Gregory J Chief Executive Officer | Award of Options | 89,474 | 0.000 – 0.000 | 211,874 | $0.0 |
Smrdel Brian J Chief Financial Officer | Award of Options | 15,000 | 0.000 – 0.000 | 15,000 | $0.0 | |
Ackermann Lisa A Officer | Award of Options | 35,000 | 0.000 – 0.000 | 99,132 | $0.0 | |
7/12/13 | Dann Mitchell Director | Purchase | 20,000 | 0.300 – 0.300 | 445,249 | $6.0 K |
7/10/13 | Fluet Gregory J Chief Executive Officer | Purchase | 25,000 | 0.240 – 0.240 | 122,400 | $6.0 K |
7/9/13 | Ackermann Lisa A Officer | Purchase | 18,500 | 0.240 – 0.240 | 64,132 | $4.4 K |
7/5/13 | Fluet Gregory J Chief Executive Officer | Purchase | 66,400 | 0.170 – 0.210 | 97,400 | $12.8 K |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |